Essential reading for the healthcare business
 
 
Remember me:
Skip Navigation LinksHealthInvestor article
Deltex makes loss – but seals NHS Supply Chain deal

Blood monitoring group Deltex Medical remained loss-making last year, but continued to position itself as a major supplier to the NHS.

In results for the year ended 31 December 2011, the company reported an operating loss of £1.4 million – the same as the previous year.

Revenue also remained flat at £6.3 million as the company announced a loss per share of one pence.

However, Deltex chairman Nigel Keen claimed the company “is in an exciting and unique position” after the company also announced its selection, through a tender process, to sell cardiac output monitoring equipment to the NHS in England through NHS Supply Chain.

The deal means NHS hospitals are able to purchase Deltex Medical's products from NHS Supply Chain rather than go through a separate tendering process under EU procurement rules. The agreement covers an initial period of two years, followed by the opportunity to extend for up to a further two years.

“The NHS, the world's largest healthcare provider is actively pursuing the rapid and wide-scale implementation of our products,” said Keen. “We are making considerable advances towards creating similar opportunities in other major healthcare systems around the world.”

In March 2011, the clinical watchdog NICE recommended that Deltex’s CardioQ-ODM product be considered for use in all patients undergoing major and high risk surgery.

Posted on: 07/03/2012

Latest news stories

19/11/2018
Health Education England has appointed Sir David Behan as chair – effective from 1 December.
19/11/2018
NHS England has lifted the safety restrictions which limited the types of patients eligible to use GP at Hand services following a NHS clinical review.
16/11/2018
Care provider Regard Group has appointed Tracy Kite (pictured) as director of learning and leadership development.
15/11/2018
The McAvoy Group has been awarded a £15 million contract for the offsite construction of a new wing at Northumbria Specialist Emergency Care Hospital, Cramlington.
14/11/2018
Independent investment manager Albion Capital has invested £5 million in The Evewell, a fully-integrated medical centre specialising in reproductive and gynaecological health.


Civica


HealthInvestor blog
The Care Quality Commission is finding its voice as a regulator, but is anyone listening?

Click here to view the HealthInvestor blog


An interest in people rather than machines led to Andrew Lennox dedicating his career to improving patient outcomes
The Care Quality Commission’s latest summary of the state of health and social care points to an unfair and fragmented system
Echo co-founder Stephen Bourke tells Jack Carter how his app is simplifying the repeat prescription process
With the care village market still very much in its infancy in the UK, perhaps two of the biggest questions facing every care village developer, investor and operator are how much can we sell our care village apartments for, and will they hold their value? Carterwood director Ben Hartley provides some answers
Vet sector consolidation means the risk of CMA intervention is increasing, say Andrew Taylor and Nick Warren, partners at Aldwych Partners

Click here to search all feature articles



Deal in the spotlight

Elysium Healthcare's acquisition of LCP takes the group portfolio to more than 60 homes in just two years
Read more


Christie + Co

my images



Veterinary

Vet sector consolidation means the risk of CMA intervention is increasing, say Andrew Taylor and Nick Warren, partners at Aldwych Partners
Read more